|
Market Closed -
Euronext Paris
00:55:00 13/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 87.98 EUR | +1.58% |
|
+4.61% | +6.36% |
| 08:05am | Windward Bio Group IPO of 10.3M Shares Prices at $17 Each | DJ |
| 08:01am | Novo Holdings-backed Windward Bio raises $175 million in US IPO | RE |
Company Valuation: Sanofi
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,194 | 112,665 | 112,549 | 116,968 | 100,655 | 105,406 | - | - |
| Change | - | 1.32% | -0.1% | 3.93% | -13.95% | 4.72% | - | - |
| Enterprise Value (EV) 1 | 121,177 | 119,102 | 120,342 | 125,740 | 111,663 | 117,049 | 113,327 | 109,709 |
| Change | - | -1.71% | 1.04% | 4.49% | -11.2% | 4.82% | -3.18% | -3.19% |
| P/E | 17.8x | 16.7x | 20.8x | 20.4x | 12.9x | 13.9x | 11.7x | 9.99x |
| PBR | 1.62x | 1.5x | 1.52x | 1.51x | 1.41x | 1.42x | 1.33x | 1.24x |
| PEG | - | 2.07x | -1.1x | 3.14x | 0.3x | -16.95x | 0.6x | 0.6x |
| Capitalization / Revenue | 2.94x | 2.62x | 2.61x | 2.85x | 2.31x | 2.18x | 2.04x | 1.93x |
| EV / Revenue | 3.21x | 2.77x | 2.79x | 3.06x | 2.56x | 2.42x | 2.19x | 2.01x |
| EV / EBITDA | 9.95x | 8.14x | 8.44x | 9.76x | 8.22x | 7.72x | 6.9x | 6.17x |
| EV / EBIT | 11.3x | 9.13x | 9.5x | 11.1x | 9.19x | 8.55x | 7.79x | 6.98x |
| EV / FCF | 15x | 14x | 14.2x | 21.1x | 13.8x | 14.5x | 11.6x | 10x |
| FCF Yield | 6.68% | 7.12% | 7.04% | 4.74% | 7.24% | 6.92% | 8.6% | 9.97% |
| Dividend per Share 2 | 3.33 | 3.56 | 3.76 | 3.92 | 4.12 | 4.259 | 4.495 | 4.779 |
| Rate of return | 3.76% | 3.96% | 4.19% | 4.18% | 4.98% | 4.84% | 5.11% | 5.43% |
| EPS 2 | 4.97 | 5.37 | 4.31 | 4.59 | 6.4 | 6.348 | 7.511 | 8.806 |
| Distribution rate | 67% | 66.3% | 87.2% | 85.4% | 64.4% | 67.1% | 59.8% | 54.3% |
| Net sales 1 | 37,761 | 42,997 | 43,070 | 41,081 | 43,626 | 48,434 | 51,676 | 54,525 |
| EBITDA 1 | 12,183 | 14,627 | 14,259 | 12,889 | 13,583 | 15,168 | 16,429 | 17,790 |
| EBIT 1 | 10,714 | 13,040 | 12,670 | 11,343 | 12,149 | 13,695 | 14,540 | 15,728 |
| Net income 1 | 6,223 | 6,720 | 5,400 | 5,744 | 7,813 | 7,676 | 9,238 | 10,825 |
| Net Debt 1 | 9,983 | 6,437 | 7,793 | 8,772 | 11,008 | 11,643 | 7,921 | 4,303 |
| Reference price 2 | 88.58 | 89.84 | 89.76 | 93.74 | 82.72 | 87.98 | 87.98 | 87.98 |
| Nbr of stocks (in thousands) | 1,255,293 | 1,254,060 | 1,253,891 | 1,247,793 | 1,216,810 | 1,198,069 | - | - |
| Announcement Date | 4/2/22 | 3/2/23 | 1/2/24 | 30/1/25 | 29/1/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 13.64x | 2.36x | 7.61x | 4.92% | 115B | ||
| 42.06x | 14.21x | 30.18x | 0.47% | 1,280B | ||
| 41.04x | 6.89x | 19.37x | 1.9% | 675B | ||
| 37.61x | 8.63x | 17.8x | 2.34% | 521B | ||
| 21.6x | 5.24x | 13.13x | 2.49% | 386B | ||
| 104.47x | 5.96x | 25.4x | 2.31% | 363B | ||
| 23.92x | 5.8x | 14.13x | 2.74% | 301B | ||
| 24.1x | 4.84x | 13.6x | 1.8% | 286B | ||
| 24.17x | 7.41x | 13.62x | 2.16% | 253B | ||
| -39.88x | 7.38x | 46.48x | 1.95% | 211B | ||
| Average | 29.27x | 6.87x | 20.13x | 2.31% | 439B | |
| Weighted average by Cap. | 36.62x | 8.73x | 22.21x | 1.77% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SAN Stock
- Valuation Sanofi
Select your edition
All financial news and data tailored to specific country editions
















